Rong Chen

Chief Tech/Sci/R&D Officer at JHL BIOTECH, INC.

Health Technology

Consumer Services

Profile

Rong Chen is currently the Chief Medical Officer at Eden Biologics, Inc. He previously worked as the Chief Medical Officer at CASI Pharmaceuticals,.
Inc. Chen received a doctorate degree from the University of Adelaide in 1989 and an undergraduate degree from Shandong Medical University.

Rong Chen active positions

Companies	Position	Start
JHL BIOTECH, INC.	Chief Tech/Sci/R&D Officer	2017-12-31

All active positions of Rong Chen

Former positions of Rong Chen

Companies	Position	End
CASI Pharmaceuticals, Inc. /Old/ CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.	Chief Tech/Sci/R&D Officer	-

See the detail of Rong Chen's experience

Training of Rong Chen

University of Adelaide	Doctorate Degree
Shandong Medical University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rong Chen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
CASI Pharmaceuticals, Inc. /Old/ CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.	Health Technology
Eden Biologics, Inc. Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan.	Health Technology